Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94305
Phone+1 415-353-2273
Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Neurology, 1992 - 1995- University of California (San Francisco)Internship, Internal Medicine, 1991 - 1992
Johns Hopkins University School of MedicineClass of 1991- University of California (San Francisco)Fellowship, Clinical Neurophysiology
Certifications & Licensure
CA State Medical License 1992 - 2028
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease Start of enrollment: 2005 Jun 01
- Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 3 citationsEnhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project.Marjan J Meinders, William J Marks, Sabine B M van Zundert, Ritu Kapur, Bastiaan R Bloem
Journal of Parkinson's Disease. 2023-01-01 - 50 citationsNew directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.Adam L. Boxer, Michael Gold, Howard Feldman, Bradley F. Boeve, Susan Dickinson
Alzheimer's & Dementia. 2020-01-01 - 40 citationsThe Project Baseline Health Study: a step towards a broader mission to map human health.Kristine Arges, Themistocles Assimes, Vikram Bajaj, Suresh Balu, Mustafa R Bashir
NPJ Digital Medicine. 2020-01-01
Press Mentions
Verily, LivaNova Kick off Study of Nerve Stimulation for Treatment-Resistant DepressionApril 26th, 2021- LivaNova Partners with Verily for RECOVER Clinical StudyFebruary 27th, 2020
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat DepressionFebruary 26th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
